1J. Padagas,M. Colloton,V. Shalhoub,P. Kostenuik,S. Morony,L. Munyakazi,M. Guo,D. Gianneschi,E. Shatzen,Z. Geng,H.-L. Tan,C. Dunstan,D. Lacey,D. Martin. The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism[J] 2006,Calcified Tissue International(1):35～44
2Shigehiro Inoue,Motoyuki Horii,Takeshi Asano,Mikihiro Fujioka,Taku Ogura,Masahiko Shibatani,Wook-Choel Kim,Masako Nakagawa,Takashi Tanaka,Yoshio Hirota,Toshikazu Kubo. Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation[J] 2003,Journal of Orthopaedic Science(6):751～756
7Vidal NO,Brandstrom H,Jonsson KB.et al.Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells:down-regulation by glucocorticoids.J Endocrinol,1998,159(1):191-195.
8Sugano N,Kubo T,Takaoka K,et al.Diagnostic criteria for nontraumatic osteonecrosis of the femoral head.A multicentre study.J Bone Joint Surg Br,1999,81(4):590-595.
9Valimaki MJ.Kinnunen K,Volin L,et al.A prospective study of bone loss and turnover after allo geneic bone marrow transplantation:effect of calcium supplementation with or without calcitonin.Bone Marrow Transplant,1999,23(4):355-361.
10Atkinson K,Cohen M,Biggs J,et al.Avasculsr necrosis of the femond head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation:effective therapy with hip arthroplasty.Bone Marrow Transplant,1987,2(4):421-426.
